COMPARISON RESULTS OF THE INTRACARDIAC ELECTROPHYSIOLOGICAL STUDY IN PATIENTS WITH TYPICAL ATRIAL FLUTTER AND FIBRILLATION

Aim. Comparison study of the parameters of intracardiac electrophysiological study (EPS) in patients with the typical atrial flutter (TAF) and atrial fibrillation (AF), of the courses as isolated types of arrhythmia.

Material and methods. Totally, 82 patients included (59 (72%) males, mean age 55±10 y.o.), directed for catheter ablation procedure for TAF or AF. Depending on the anamnesis of arrhythmia, patients were selected to 4 groups: 1 — isolated TAF (n=26, 32%), 2 — AF with “spontaneous” TAF (n=27, 33%), 3 — AF and TAF, when the latter had been registered only under treatment by antiarrhythmics of IC and III classes (n=14, 17%), 4 — isolated AF (n=15, 18%). All patients underwent EPS within sinus rhythm and no antiarrhythmic therapy. During EPS the following parameters were defined: P-wave duration, time of interand intra-atrial conduction, effective refractory periods (ERP) in various areas of the atria. By the results of EPS, comparative statistical study performed of the listed parameters in the groups.

Results. Patients with TAF (groups 1, 2, 3), in difference with isolated AF (group 4) had significantly longer P-wave and inter-atrial conduction time. Analysis of ERP showed similar heterogeneity of the parameters in different areas of the atria in all studied groups: the lowest ERP is found in the lateral area of the right atrium, the highest — in the distal area of coronary sinus. Intergroup differences by these parameters were non-significant.

Conclusion. For TAF patients, as an isolated disorder or with AF, the characteristical is significant prolongation of the inter-atrial conduction time, that might expain tendency to tachiarrhythmias of re-entry genesis.

1. Granada J, Uribe W, Chyou PH, et al. Incidence and predictors of atrial flutter in the general population. J Am Coll Cardiol 2000; 36: 2242-6.

2. Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 2016; 37: 2893-962.

3. Waldo AL. Atrial flutter. In PJ Podrid, PR Kowey (eds.): Cardiac Arrhythmia: Mechanisms, Diagnosis, and Management. 2nd ed. Baltimore: Williams & Wilkens, 2001: 501-16.

4. Calkins H, Kuck KH, Cappato R, et al. 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace 2012; 14: 528-606.

5. Bertaglia E, Zoppo F, Bonso A, et al. Long-term follow-up of radiofrequency catheter ablation of atrial flutter: clinical course and predictors of atrial fibrillation occurrence. Heart 2004; 90: 59-63.

6. Ellis K, Wazni O, Marrouche N, et al. Incidence of atrial fibrillation post-cavotricuspid isthmus ablation in patients with typical atrial flutter: left-atrial size as an independent predictor of atrial fibrillation recurrence. J Cardiovasc Electrophysiol 2007; 18: 799-802.

7. Waldo AL, Feld GK. Inter-relationships of atrial fibrillation and atrial flutter: mechanisms and clinical implications. J Am Coll Cardiol 2008; 51: 779-86.

8. Huang DT, Monahan KM, Zimetbaum P, et al. Hybrid pharmacologic and ablative therapy: a novel and effective approach for the management of atrial fibrillation. J Cardiovasc Electrophysiol 1998; 9: 462-9.

9. Chinitz JS, Gerstenfeld EP, Marchlinski FE, et al. Atrial fibrillation is common after ablation of isolated atrial flutter during long-term follow-up. Heart Rhythm 2007, pp. 1029-33. 10. Novikov PS, Shlevkov NB, Pevzner AV, et al. Incidence and risk factors of atrial fibrillation after cavotricuspid catheter ablation in patients with “isolated” typical atrial flutter. Vestn aritmol 2016; 84: 5-11. Russian (Новиков П.С., Шлевков Н.Б., Певзнер А.В. и др. Частота возникновения и факторы риска развития фибрилляции предсердий после радиочастотной катетерной аблации кавотрикуспидального истмуса у больных с “изолированным” типичным трепетанием предсердий. Вестник аритмологии 2016, 84: 5-11).

10. Baykan M, Celik S, Erd`l C, et al. Effects of P-wave dispersion on atrial fibrillation in patients with acute anterior wall myocardial infarction. Ann. Noninvasive Electrocardiology. 2003, pp. 101-6.

11. Schumacher B, Jung W, Lewalter T, et al. Radiofrequency ablation of atrial flutter due to administration of class IC antiarrhythmic drugs for atrial fibrillation. Am J Cardiol 1999; 83: 710-3.

12. Medi C, Teh AW, Roberts-Thomson K, et al. Right atrial remodeling is more advanced in patients with atrial flutter than with atrial fibrillation. J Cardiovasc Electrophysiol 2012; 23: 1067-72.

13. Simpson RJ Jr, Amara I, Foster JR, et al. Thresholds of refractory periods, and conduction times of the normal and diseased human atrium. Am Heart J 1988; 116: 1080-90.

14. Kühlkamp V, Haasis R, Seipel L. Atrial vulnerability and electrophysiology determined in patients with and without paroxysmal atrial fibrillation. Pacing Clin Electrophysiol 1992; 15: 71-80.